This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1985 Jun;315(6020):546.

doi: 10.1038/315546a0.

Oncogenes homologous to steroid receptors?

M Sluyser, J Mester

PMID: 2989691
DOI: 10.1038/315546a0

Oncogenes homologous to steroid receptors?

M Sluyser et al. Nature. 1985 Jun.

. 1985 Jun;315(6020):546.

doi: 10.1038/315546a0.

Authors

M Sluyser, J Mester

PMID: 2989691
DOI: 10.1038/315546a0

No abstract available

PubMed Disclaimer

Similar articles

Nuclear hormone receptor variants: their role in malignancy and progression to hormone resistance in cancer.
Sluyser M. Sluyser M. Acta Endocrinol (Copenh). 1991;125 Suppl 1:48-53. Acta Endocrinol (Copenh). 1991. PMID: 1666242 Review.
Transforming genes of human malignancies.
Aaronson SA, Tronick SR. Aaronson SA, et al. Carcinog Compr Surv. 1985;10:35-49. Carcinog Compr Surv. 1985. PMID: 2998614 Review. No abstract available.
[Human oncogenes].
Yamamoto T. Yamamoto T. Rinsho Byori. 1985 Nov;33 Spec No 65:87-95. Rinsho Byori. 1985. PMID: 3005719 Review. Japanese. No abstract available.
The company they keep. Fifth Annual Meeting on Oncogenes sponsored by the Foundation for Advanced Cancer Studies, Inc., Frederick, MD, USA, June 27-July 1, 1989.
Cross SL. Cross SL. New Biol. 1989 Nov;1(2):141-3. New Biol. 1989. PMID: 2577367 No abstract available.
Oncogenes from hormone receptors.
Parker MG. Parker MG. J Endocrinol. 1987 Jan;112(1):1-2. doi: 10.1677/joe.0.1120001. J Endocrinol. 1987. PMID: 3029257 No abstract available.

See all similar articles

Cited by

Oestrogen receptor activity in intraduct and invasive breast carcinomas.
Hawkins RA, Tesdale AL, Ferguson WA, Going JJ. Hawkins RA, et al. Breast Cancer Res Treat. 1987;9(2):129-33. doi: 10.1007/BF01807365. Breast Cancer Res Treat. 1987. PMID: 3040158
Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.
Foekens JA, Portengen H, Look MP, van Putten WL, Thirion B, Bontenbal M, Klijn JG. Foekens JA, et al. Br J Cancer. 1994 Dec;70(6):1217-23. doi: 10.1038/bjc.1994.476. Br J Cancer. 1994. PMID: 7981080 Free PMC article.
Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators.
Jordan VC, Curpan R, Maximov PY. Jordan VC, et al. J Natl Cancer Inst. 2015 Apr 2;107(6):djv075. doi: 10.1093/jnci/djv075. Print 2015 Jun. J Natl Cancer Inst. 2015. PMID: 25838462 Free PMC article.
Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin.
Berthelet J, Foroutan M, Bhuva DD, Whitfield HJ, El-Saafin F, Cursons J, Serrano A, Merdas M, Lim E, Charafe-Jauffret E, Ginestier C, Ernst M, Hollande F, Anderson RL, Pal B, Yeo B, Davis MJ, Merino D. Berthelet J, et al. Cancers (Basel). 2022 May 13;14(10):2404. doi: 10.3390/cancers14102404. Cancers (Basel). 2022. PMID: 35626009 Free PMC article.
Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer.
Khatpe AS, Adebayo AK, Herodotou CA, Kumar B, Nakshatri H. Khatpe AS, et al. Cancers (Basel). 2021 Jan 20;13(3):369. doi: 10.3390/cancers13030369. Cancers (Basel). 2021. PMID: 33498407 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group